Bernard Asselain

19.6k total citations
323 papers, 11.0k citations indexed

About

Bernard Asselain is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bernard Asselain has authored 323 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Oncology, 118 papers in Cancer Research and 82 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bernard Asselain's work include Breast Cancer Treatment Studies (90 papers), Cancer Treatment and Pharmacology (38 papers) and Cancer Genomics and Diagnostics (36 papers). Bernard Asselain is often cited by papers focused on Breast Cancer Treatment Studies (90 papers), Cancer Treatment and Pharmacology (38 papers) and Cancer Genomics and Diagnostics (36 papers). Bernard Asselain collaborates with scholars based in France, United States and United Kingdom. Bernard Asselain's co-authors include Alain Fourquet, P Pouillart, Thierry Dorval, Laurence Desjardins, J.C. Durand, Xavier Sastre‐Garau, Philippe Beuzeboc, Rémy Salmon, Youlia Kirova and Anne Vincent‐Salomon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Genetics.

In The Last Decade

Bernard Asselain

315 papers receiving 10.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bernard Asselain 5.2k 4.4k 2.6k 2.1k 2.0k 323 11.0k
Richard Sposto 3.4k 0.6× 1.6k 0.4× 2.8k 1.1× 2.0k 1.0× 3.3k 1.6× 282 13.4k
Herman R. Menck 5.7k 1.1× 1.7k 0.4× 1.3k 0.5× 4.0k 1.9× 1.8k 0.9× 131 13.1k
Rob A.�E.�M. Tollenaar 8.1k 1.5× 2.8k 0.7× 2.4k 0.9× 2.6k 1.2× 3.7k 1.8× 315 15.6k
James A. Hayman 2.6k 0.5× 3.4k 0.8× 1.9k 0.7× 4.3k 2.0× 569 0.3× 250 10.9k
Carien L. Creutzberg 2.9k 0.6× 1.9k 0.4× 1.5k 0.6× 1.7k 0.8× 1.9k 1.0× 208 15.5k
Robert R. McWilliams 5.9k 1.1× 1.9k 0.4× 1.1k 0.4× 1.9k 0.9× 2.4k 1.2× 206 8.4k
Terry L. Smith 7.7k 1.5× 4.2k 1.0× 2.9k 1.1× 2.6k 1.3× 2.8k 1.4× 154 16.0k
Walter M. Gregory 3.9k 0.7× 928 0.2× 1.3k 0.5× 1000 0.5× 3.9k 1.9× 203 9.3k
Marie Overgaard 4.3k 0.8× 7.3k 1.7× 3.3k 1.3× 2.6k 1.3× 1.1k 0.5× 139 12.5k
Yves Humblet 13.0k 2.5× 2.4k 0.5× 2.8k 1.1× 5.6k 2.7× 2.8k 1.4× 174 15.9k

Countries citing papers authored by Bernard Asselain

Since Specialization
Citations

This map shows the geographic impact of Bernard Asselain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Asselain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Asselain more than expected).

Fields of papers citing papers by Bernard Asselain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Asselain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Asselain. The network helps show where Bernard Asselain may publish in the future.

Co-authorship network of co-authors of Bernard Asselain

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Asselain. A scholar is included among the top collaborators of Bernard Asselain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Asselain. Bernard Asselain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Classe, Jean‐Marc, Pierre Méeus, Éric Leblanc, et al.. (2023). #876 Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: the chipor randomised phase III trial. A29.1–A29. 4 indexed citations
2.
Gougis, Paul, Floriane Jochum, Kévin Bihan, et al.. (2023). Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns. JAMA Network Open. 6(10). e2339934–e2339934. 8 indexed citations
3.
Léary, Alexandra, Isabelle Laure Ray-Coquard, Bernard Asselain, et al.. (2023). LBA42 Olaparib vs placebo as maintenance therapy after platinum-based chemotherapy in advanced/metastatic endometrial cancer patients: The GINECO randomized phase IIb UTOLA trial. Annals of Oncology. 34. S1283–S1284. 11 indexed citations
4.
Joly, Florence, Dominique Vaur, Bernard Asselain, et al.. (2022). 2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study. International Journal of Gynecological Cancer. 32. A118–A119.
5.
Guilmatre, Audrey, et al.. (2022). Quelles sont les pratiques en génétique des pédiatres onco-hématologues de la SFCE ? Une enquête du groupe socle éthique CONECT-AML. Bulletin du Cancer. 109(11). 1162–1176. 1 indexed citations
6.
Crémoux, Patricia de, Anne‐Sophie Hamy, Jacqueline Lehmann‐Che, et al.. (2018). COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients. Anticancer Research. 38(3). 1485–1490. 10 indexed citations
7.
Lamy, Pierre‐Jean, Yves Allory, Anne‐Sophie Gauchez, et al.. (2017). Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review. European Urology Focus. 4(6). 790–803. 59 indexed citations
8.
Paolettí, Xavier, Bernard Asselain, Maud Kamal, et al.. (2015). Design and statistical principles of the SHIVA trial.. PubMed. 4(3). 32–32. 1 indexed citations
9.
de, Rocío Montes, Zachary A. Gurard‐Levin, Frédérique Berger, et al.. (2014). The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma. Molecular Oncology. 9(3). 657–674. 63 indexed citations
10.
Lehmann‐Che, Jacqueline, Véronique Scott, Bernard Asselain, et al.. (2013). Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab. British Journal of Cancer. 108(9). 1807–1809. 76 indexed citations
11.
Desjardins, Laurence, Livia Lumbroso‐Le Rouic, Christine Lévy‐Gabriel, et al.. (2011). Treatment of Uveal Melanoma by Accelerated Proton Beam. Developments in ophthalmology. 49. 41–57. 49 indexed citations
12.
Gravier, Eléonore, Gaëlle Pierron, Anne Vincent‐Salomon, et al.. (2010). A prognostic DNA signature for T1T2 node‐negative breast cancer patients. Genes Chromosomes and Cancer. 49(12). 1125–1134. 60 indexed citations
13.
Hupé, Philippe, Ingrid Lebigot, Charles Decraene, et al.. (2009). Genomic Profiling and Identification of High-Risk Uveal Melanoma by Array CGH Analysis of Primary Tumors and Liver Metastases. Investigative Ophthalmology & Visual Science. 50(6). 2572–2572. 90 indexed citations
14.
Soussi, Thierry, Bernard Asselain, Dalil Hamroun, et al.. (2006). Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection. Clinical Cancer Research. 12(1). 62–69. 58 indexed citations
15.
Polo, Sophie E., Stamatios Theocharis, Jerzy Klijanienko, et al.. (2004). Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells. Cancer Research. 64(7). 2371–2381. 75 indexed citations
16.
Rouzier, Roman, Jean-Marc Extra, Jerzy Klijanienko, et al.. (2002). Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes. Journal of Clinical Oncology. 20(5). 1304–1310. 265 indexed citations
17.
Resbeut, M., Christine Haie‐Méder, A Bataillard, et al.. (2002). Standards, Options et Recommandations pour la prise en charge de patientes atteintes de cancer invasif du col utérin (stade non métastatique) (version abrégée). Gynécologie Obstétrique & Fertilité. 30(7-8). 631–648. 2 indexed citations
18.
Lévy, Christine, F D'Hermiès, E Frau, et al.. (2000). [Optic neuropathy after proton-beam therapy for malignant choroidal melanoma].. PubMed. 23(6). 543–53. 14 indexed citations
19.
Sastre‐Garau, Xavier, Michel Jouve, Bernard Asselain, et al.. (1996). Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 77(1). 113–120. 327 indexed citations
20.
Pouillart, P, M Jouvet, T Palangié, et al.. (1985). [Hepatic metastases of breast cancer. Analysis of the parameters which influence the response to chemotherapy].. PubMed. 21(2). 87–90. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Sposto Breakdown of academic impact, for papers by Herman R. Menck Breakdown of academic impact, for papers by Rob A.�E.�M. Tollenaar Breakdown of academic impact, for papers by James A. Hayman Breakdown of academic impact, for papers by Carien L. Creutzberg Breakdown of academic impact, for papers by Robert R. McWilliams Breakdown of academic impact, for papers by Terry L. Smith Breakdown of academic impact, for papers by Walter M. Gregory Breakdown of academic impact, for papers by Marie Overgaard Breakdown of academic impact, for papers by Yves Humblet
Rankless by CCL
2026